GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $590,000 | 0.0% | 13,546 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $590,000 | -1.2% | 13,546 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $597,000 | +15.3% | 13,546 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $518,000 | -3.9% | 13,546 | 0.0% | 0.01% | -11.1% |
Q2 2021 | $539,000 | +10.5% | 13,546 | -0.9% | 0.01% | +12.5% |
Q1 2021 | $488,000 | -3.9% | 13,665 | -1.1% | 0.01% | -11.1% |
Q4 2020 | $508,000 | +1.8% | 13,814 | +4.2% | 0.01% | -10.0% |
Q3 2020 | $499,000 | -7.8% | 13,253 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $541,000 | +7.8% | 13,253 | 0.0% | 0.01% | -7.7% |
Q1 2020 | $502,000 | +4.4% | 13,253 | +29.4% | 0.01% | +18.2% |
Q4 2019 | $481,000 | +10.1% | 10,243 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $437,000 | +6.6% | 10,243 | 0.0% | 0.01% | +10.0% |
Q2 2019 | $410,000 | +25.8% | 10,243 | +31.5% | 0.01% | +25.0% |
Q1 2019 | $326,000 | +9.4% | 7,790 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $298,000 | -9.4% | 7,790 | -4.9% | 0.01% | 0.0% |
Q3 2018 | $329,000 | -1.2% | 8,190 | -0.9% | 0.01% | -11.1% |
Q2 2018 | $333,000 | +8.5% | 8,265 | +5.1% | 0.01% | 0.0% |
Q1 2018 | $307,000 | – | 7,865 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |